Sicor Biotech UAB

SICOR Biotech UAB develops and manufactures recombinant biopharmaceuticals.

SICOR Biotech UAB exploits proprietary, highly effective manufacturing technologies to produce moderately priced, modern recombinant therapeutics.

From the beginning in the 1970's as part of the Lithuanian Institute of Applied Enzymology, SICOR Biotech UAB has gained an expertise in biotechnology and has earned a reputation of offering high quality products for the Eastern Europe, the Far East and other markets.

SICOR Biotech UAB current product offerings include Realdiron (interferon alfa-2b human recombinant) registered in 18 countries, Biosoma (recombinant human growth hormone) registered in 11 countries, and Grasalva (filgrastim) recently registered in Lithuania. All products meet EU and USA quality requirements. In addition, SICOR Biotech UAB has a development pipeline composed of several major protein products that dominate in the world biotechnology markets today.
Is this your Organization?   Request Access

Locations


Lithuania
Vilnius
V.A. Graičiūno str. 8
Vilnius,   LT-02241
Lithuania, Europe

Contacts


CMOLocator

Production Lines

Vilnius   Cell Culture
Location: Vilnius, Lithuania
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  BatchBatch
BioReactor Scale:  1L-100L2L Bioreactor
GMP Level:  Phase I/IIPhase I/II
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  NoneNone
Additional Services
Analytical Services are Not AvailableAnalytical Services
Cell Banking is Not AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is Not AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 22MAR10

Send Inquiry about this Production Line
Vilnius   Fermentation
Location: Vilnius, Lithuania
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  MicrobialMicrobial
BioReactor Process:  BatchBatch
BioReactor Scale:  100L-2000L1000L Bioreactor
GMP Level:  Phase I/IIPhase I/II
Biosafety Level:  Not SpecifiedNot Specified
Single Use:  NoneNone
Additional Services
Analytical Services are Not AvailableAnalytical Services
Cell Banking is Not AvailableCell Banking
Cell Line Development is Not AvailableCell Line Development
Preclinical Manufacturing is Not AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 22MAR10

Send Inquiry about this Production Line

Copyright © Kymanox, All Rights Reserved.